EN
HI
Brooks Laboratories Chart
Brooks Laboratories Share Key Metrics
Volume
1.23 L
Market Cap
197.51 CR
LTQ@LTP
20@67.05
ATP
67.09
Var Margin
100 %
Circuit Range
65.13-71.97
Delivery %
0 %
Value
82.61 L
ASM/GSM
No
Market Lot
1
Summary
Brooks Laboratories share price is ₹67.05 as of 2 Jun, 2026. The stock Brooks Laboratories intraday movement has stayed between ₹65.13 and ₹71.90, while on a 52-week basis,Brooks Laboratories price 52 week high is ₹164.02 & its 52 week low is ₹36.30.
In terms of trading activity, Brooks Laboratories has recorded a volume of 123137 shares, The Brooks Laboratories has a market cap of ₹29457248 CR. The stock’s Average Traded Price (ATP) stands at ₹67.09, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 20 @ ₹67.05.
Brooks Laboratories operates within a circuit range of ₹65.13 – ₹71.97, with a Value of ₹82.61 L. The Delivery Percentage for the day is 0%. Additionally, Brooks Laboratories currently falls under the No framework, and trades with a market lot size of 1.
Brooks Laboratories Fundamentals
View MoreP/E Ratio
8.97
P/B Ratio
1.67
Div. Yield
0
Sector P/E
69.53
Sector P/B
2.99
Sec. Div. Yield
0.55
Brooks Laboratories Resistance and Support
Pivot 68.2
Resistance
First Resistance
68.9
Second Resistance
69.25
Third Resistance
69.95
Support
First Support
67.85
Second Support
67.15
Third Support
66.8
Brooks Laboratories Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-29 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
Brooks Laboratories News
Brooks Laboratories Ltd - 533543 - Announcement under Regulation 30 (LODR)-Change in Management
Brooks Laboratories appointed Mr. Prashant Rathi as Chief Executive Officer, effective June 1, 2026. He will continue to serve as the Chief Financial Officer, leveraging his 13+ years of experience and 5+ years with the company.
May 29 2026 20:21:03
Brooks Laboratories Ltd - 533543 - Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 29Th May 2026
Brooks Labs board approved Q4 FY26 cons. net profit of ₹152.30 lakhs and FY26 cons. net profit of ₹2,458.35 lakhs. The company also appointed Mr. Prashant Rathi as CEO and reaffirmed its exclusive focus on pharmaceutical operations.
May 29 2026 20:08:27
Read More
Brooks Laboratories Management
| Name | Position |
|---|---|
| Krutika Mohan Rane | Company Secretary & Compliance Officer |
| Bhushan Singh Rana | Whole Time Director |
Brooks Laboratories FAQs
The Buying Price of Brooks Laboratories share is 67.05 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Brooks Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Brooks Laboratories, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Brooks Laboratories shares is 8.97. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Brooks Laboratories shares is 1.67. Useful to assess the stock's value relative to its book value.
To assess Brooks Laboratories’s valuation compare Sector P/E, P/B which are 69.53 & 2.99 with sector averages, along with growth rates and financial metrics.
The Market Cap of Brooks Laboratories is 197.51 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Brooks Laboratories share price is 164.02 & 36.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Brooks Laboratories belongs to the Healthcare sector.
